Bristol-Myers Squibb Co (LTS:0R1F)
$ 54.48 -1.095 (-1.97%) Market Cap: 109.81 Bil Enterprise Value: 153.11 Bil PE Ratio: 0 PB Ratio: 6.41 GF Score: 84/100

Bristol-Myers Squibb Co at Cowen Healthcare Conference (Virtual) Transcript

Mar 03, 2021 / 03:20PM GMT
Release Date Price: $60.64 (-1.16%)
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good morning, and welcome to the Bristol-Myers Squibb session within the Cowen 41st Annual Healthcare Conference. We're delighted have Bristol with us again this year.

Representing the company is Samit Hirawat, who's Executive Vice President and Chief Medical Officer. There's so many new developments and new products and new initiatives at Bristol that it's a full-time job to keep track of them all. But the best person on the planet to give us an update on all of them is Samit. So Samit, thank you so much for spending this time with us.

Samit Hirawat
Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Global Drug Development

Thank you, Steve.

Questions & Answers

Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

I'd like to start out by asking, Bristol has numerous -- has had numerous positive clinical trial readouts over the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot